Translational medicine researchers have been procuring human biospecimens directly from patients with Sanguine for over 10 years and published in 140+ peer-reviewed articles.
Results relying on PBMCs obtained through Sanguine’s 70,000+ research-ready participant network have been published in Cell, Nature Communications, and Science Translational Medicine, among others. Check out these examples: |